Lloyd Miller, MD, PhD

home / authors / lloyd-miller-md-phd

Articles

Lloyd Miller, MD, PhD: Delving Into JNJ-2113 Data for Plaque Psoriasis

Lloyd Miller, MD, PhD: Delving Into JNJ-2113 Data for Plaque Psoriasis

Emma Andrus, Associate Editor;Lloyd Miller, MD, PhD
February 20th 2024

Miller, Vice President, Immunodermatology Disease Area Leader, Johnson & Johnson, spoke with Dermatology Times about recently published data supporting JNJ-2113's potential in this indication.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
POLL: Have Your Patients Asked About Cabtreo for Acne?
Published: December 4th 2023 | Updated: March 5th 2025
POLL: Have Your Patients Asked About Cabtreo for Acne?
POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation
Published: February 28th 2025 | Updated: March 5th 2025
POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation
Diamant Thaçi, MD, PhD: Understanding the Impact of Nemolizumab Efficacy Post Approvals in EU, UK, and Switzerland
Published: February 26th 2025 | Updated: March 5th 2025
Diamant Thaçi, MD, PhD: Understanding the Impact of Nemolizumab Efficacy Post Approvals in EU, UK, and Switzerland
Christophe Piketty, MD, PhD: Nemolizumab's Unique Mechanism of Action and Next Steps Globally
Published: February 26th 2025 | Updated: March 5th 2025
Christophe Piketty, MD, PhD: Nemolizumab's Unique Mechanism of Action and Next Steps Globally
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Published: November 17th 2023 | Updated: March 5th 2025
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
© 2025 MJH Life Sciences

All rights reserved.